GlassScriptPhysician profile
Steven C Lochow
NPI 1538187364
$145,666.09
in general payments reported to CMS, 2019-2025
23 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $15K · 2021: $9,502 · 2022: $25K · 2023: $9,547 · 2024: $8,646 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,704 · Travel and Lodging: $5,262 · Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,579.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,704.00 |
| Travel and Lodging | $5,261.92 |
| Food and Beverage | $1,784.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $92,367.40 | 2019-2025 | Actis, Velys, Reclaim |
| Medtronic, INC. | $22,732.89 | 2021-2025 | Aquamantys(Tm) |
| Medtronic USA, INC. | $14,632.75 | 2019-2020 | |
| Smith+Nephew, INC. | $7,108.31 | 2019-2023 | Evos |
| Arthrex, INC. | $6,444.01 | 2023-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,225.33 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $419.02 | 2020-2024 | G7, Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Depuy Synthes Sales INC. | $193.14 | 2021-2023 | Actis, Emphasys, Kincise |
| Innovation Technologies INC | $117.63 | 2021-2023 | Irrisept |
| Bone Support INC. | $95.21 | 2020 | |
| Stryker Corporation | $67.24 | 2022-2023 | T2 Alpha |
| Osteocentric Technologies, INC. | $44.84 | 2020 | |
| Ferring Pharmaceuticals INC. | $31.22 | 2023-2025 | Euflexxa |
| Solventum Corporation | $24.32 | 2024 | Prevena, V.A.C. Veraflo |
| Abbott Laboratories | $22.91 | 2023 | Proclaim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $22.51 | 2025 | Senza |
| Si-Bone, INC. | $20.00 | 2024 | |
| Avanos Medical | $19.00 | 2024 | Trivisc Sodium Hyaluronate |
| Paratek Pharmaceuticals, INC. | $18.28 | 2021 | |
| Endo Pharmaceuticals INC. | $17.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2022 | |
| Abbvie INC. | $14.26 | 2022 | |
| Merck Sharp & Dohme LLC | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lochow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.